United States News Todas as matérias

Takeda (NYSE:TAK) announced that Japan’s Ministry of Health, Labour and Welfare approved ORZEYFUL (oveporexton) for adults with narcolepsy type 1, making it the company’s third global approval for the treatment.

Acadia Pharmaceuticals (NASDAQ:ACAD) announced that the European Commission approved DAYBU (trofinetide) for Rett syndrome in adults and pediatric patients aged five years and older, making it the first approved Rett syndrome treatment in the European Union.

Descartes Systems Group (NASDAQ:DSGX) acquired the transportation management system provider Tai for $100 million to expand its logistics capabilities for freight brokers.

La Rosa Holdings (NASDAQ:LRHC) reported first-half 2026 revenue of $28.6 million, down from $34.9 million in 2025, while gross profit increased and operating losses narrowed.

Biogen (NASDAQ:BIIB) and Eisai announced that LEQEMBI IQLIK, a once-weekly subcutaneous lecanemab-irmb autoinjector, is now available in the United States for adults with early Alzheimer’s disease.

Kimbell Royalty Partners (NYSE:KRP) issued updated third and fourth quarter 2026 guidance after completing the Mesa Acquisition and Drop Down transaction, valued at approximately $145.9 million and $221.2 million respectively.

• The Home Depot (NYSE:HD) reported fiscal Q2 2026 sales of $47.9 billion, up 5.7%, as comparable sales increased 1.7%.
• Lowe’s, Tractor Supply, Floor & Decor and Williams-Sonoma are facing similar consumer spending pressures across home projects, repairs and discretionary purchases.
• The sector outlook depends on housing activity, interest rates, consumer confidence and whether delayed renovation demand returns.

• Target (NYSE:TGT) reported $26.5 billion in second-quarter net sales, up 5.3%, while $994 million in tariff refunds lifted diluted EPS to $4.11.
• Large U.S. value retailers are still growing sales, but profitability varies sharply as companies balance pricing, digital fulfillment and operating costs.
• Tariffs, fuel and freight costs, consumer price sensitivity and aggressive value positioning remain key variables for the sector through 2026.

• Gina Rinehart's Hancock Prospecting purchased eight million shares of SpaceX for US$1.37 billion. The firm stated this diversifies its portfolio away from Western Australian mining operations.
• The transaction drove a 72% increase in the firm's US equities portfolio to US$5.71 billion. These listed space peers share massive capitalisation metrics driven by institutional tech allocations.
• Developing orbital infrastructure requires extreme capital intensity. Aerospace executives project that scaling launch vehicles will demand continuous funding before reaching profitability.

• Klarna posted Q2 2026 revenue of $1.042 billion (+27%) and GMV of $36.6 billion (+18%), while turning a $46 million operating loss a year earlier into a $27 million operating profit and $9 million net income.
• Despite stronger profitability and transaction margins, Klarna cut its full‑year GMV outlook to $149–151 billion, citing weaker German consumer spending and ongoing sensitivity to credit conditions.
• Compared with peers, Klarna is larger than Affirm and Sezzle on GMV but faces similar pressure to show that higher per‑transaction economics can offset slower volume growth, while Block and PayPal embed BNPL within much broader payments ecosystems.

Scholar Rock (NASDAQ:SRRK) removed Catalent Indiana as a commercial fill-finish facility from its apitegromab Biologics License Application (BLA) for spinal muscular atrophy (SMA), with FDA review continuing using an alternate facility.

Yatra Online (NASDAQ:YTRA) confirmed that Magna Holdings launched an unsolicited tender offer to purchase up to 20 million ordinary shares of Yatra at $1.10 per share in cash.

Alvotech (NASDAQ:ALVO) entered a strategic licensing and commercialization agreement with Lotus Pharmaceutical covering two biosimilar candidates, AVT34 and AVT87, with potential value of approximately $150 million.

FedEx (NYSE:FDX) declared a quarterly cash dividend of $1.22 per share on common stock, payable on October 1, 2026, to shareholders of record as of September 14, 2026.

Vivakor (NASDAQ:VIVK) reported second-quarter 2026 revenue of $32.1 million, up 10% year over year, as expanded crude oil Supply & Trading activities supported growth.

reAlpha Tech Corp (NASDAQ:AIRE) completed its acquisition of InstaMortgage on August 19, 2026, adding direct mortgage lending capabilities to its real estate technology platform.

Milestone Pharmaceuticals (NASDAQ:MIST) enrolled the first patient in ReVeRA-301, a pivotal Phase 3 trial evaluating etripamil nasal spray for atrial fibrillation with rapid ventricular rate (AFib-RVR).

Werewolf Therapeutics (NASDAQ:HOWL) and Ambros Therapeutics entered an all-stock merger agreement that will create a Nasdaq-listed biotechnology company focused on developing neridronate for Complex Regional Pain Syndrome Type 1 (CRPS-1).

Permian Basin Royalty Trust (NYSE:PBT) declared an August 2026 cash distribution of $871,663.17, or $0.018701 per unit, based on production from its underlying royalty properties.

Petrobras (NYSE:PBR) submitted an expression of interest to explore four offshore blocks in Ghana’s Keta Basin as part of efforts to expand its oil and gas reserves.

AbbVie (NYSE:ABBV) reported Phase 1b lung cancer data showing objective response rates of 90% in squamous and 75.9% in non-squamous advanced NSCLC with ABBV-1480 plus platinum chemotherapy.

PPL (NYSE:PPL) declared a quarterly common stock dividend of $0.2850 per share, payable on October 1, 2026, to shareholders of record as of September 10, 2026.

Ubiquiti (NYSE:UI) reported fiscal 2026 revenue of $3.3 billion and GAAP diluted earnings per share of $15.85 for the year ended June 30, 2026.

Synaptics (NASDAQ:SYNA) announced that Chief Financial Officer Ken Rizvi has resigned effective immediately and will support the transition as an advisor through September 30, 2026.